Concerning the pro-oxidant XO enzyme, our results revealed a higher XO activity in PMNs and MNs from NDD-CKD and PD patients, which can promote ROS overproduction, as well as exert cytotoxicity on the kidney and the vascular endothelium during CKD progression [16]. The gene discussed is XDH; the disease is chronic kidney disease.